Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 67627058

  Document Type - Tender Notices

Description - The health insurance companies involved are pursuing the goal of concluding discount agreements on the active substance metformin/dapagliflozin (combination of active substances) with all suitable pharmaceutical companies in accordance with Section 1 30c (1) SGB V. The contract is concluded as part of the open-house original procedure of the health insurance companies: Individual negotiations about the content of the contract are not conducted, uniform conditions apply. The health insurance companies do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on August 1st, 2023. The contract ends on July 31, 2025 at the latest, reg

Gt Ref Id - 67627058

Deadline - Jul 31, 2025